TG Therapeutics Inc.

NASDAQ: TGTX · Real-Time Price · USD
27.71
-0.37 (-1.32%)
At close: Aug 18, 2025, 3:59 PM
27.76
0.16%
After-hours: Aug 18, 2025, 06:11 PM EDT

TG Therapeutics Revenue

TG Therapeutics reported an annual revenue of $329M, reflecting a 40.8% growth. For the quarter ending June 30, 2025, TG Therapeutics generated $141.15M in revenue.
Revenue (ttm)
329M
Revenue Growth
40.8%
Price / Sales Ratio
13.29
Revenue / Employee
934.67K
Employees
352
Market Cap
4.4B

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Dec 31, 2024 329M +40.80%
Dec 31, 2023 233.66M +8290.02%
Dec 31, 2022 2.79M -58.36%
Dec 31, 2021 6.69M +4300.66%
Dec 31, 2020 152K n/a
Dec 31, 2019 152K n/a
Dec 31, 2018 152K -0.25%
Dec 31, 2017 152.38K n/a
Dec 31, 2016 152.38K n/a
Dec 31, 2015 152.38K n/a
Dec 31, 2014 152.38K n/a
Dec 31, 2013 152.38K +699.98%
Dec 31, 2012 19.05K +Infinity%
Dec 31, 2011 0 n/a
Dec 31, 2010 0 n/a
Dec 31, 2009 0 n/a
Dec 31, 2008 0 n/a
Dec 31, 2007 0 n/a
Dec 31, 2006 0 n/a
Dec 31, 2005 0 n/a
Dec 31, 2004 0 n/a
Dec 31, 2003 0 -100.00%
Dec 31, 2002 500K -81.56%
Dec 31, 2001 2.71M -49.39%
Dec 31, 2000 5.36M +346.58%
Dec 31, 1999 1.2M -60.00%
Dec 31, 1998 3M +2900.00%
Dec 31, 1997 100K n/a
Dec 31, 1996 100K n/a
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.